Khas Jungle Medi Food Processing Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 10-01-2025
- Paid Up Capital ₹ 1.00 Cr
as on 10-01-2025
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.04 Cr
as on 10-01-2025
- Revenue -57.32%
(FY 2017)
- Profit -55.11%
(FY 2017)
- Ebitda 852.84%
(FY 2017)
- Net Worth 300.04%
(FY 2017)
- Total Assets 85.15%
(FY 2017)
About Khas Jungle Medi Food Processing
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹1.04 Cr.
Rakhi Guin and Arkajeet Guin serve as directors at the Company.
- CIN/LLPIN
U15497WB2003PTC097364
- Company No.
097364
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2003
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Medinipur, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Khas Jungle Medi Food Processing?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakhi Guin  | Director | 26-Apr-2021 | Current |
| Arkajeet Guin | Director | 25-Sep-2013 | Current |
Financial Performance of Khas Jungle Medi Food Processing.
Khas Jungle Medi Food Processing Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 57.32% decrease. The company also saw a substantial fall in profitability, with a 55.11% decrease in profit. The company's net worth Soared by an impressive increase of 300.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Khas Jungle Medi Food Processing?
In 2017, Khas Jungle Medi Food Processing had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹1.04 Cr
₹0
Charges Breakdown by Lending Institutions
- United Bank Of India : 1.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Apr 2004 | United Bank Of India | ₹1.04 Cr | Open |
How Many Employees Work at Khas Jungle Medi Food Processing?
Khas Jungle Medi Food Processing has a workforce of 15 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Khas Jungle Medi Food Processing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Khas Jungle Medi Food Processing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
